Staurosporine analogues from microbial and synthetic sources and their biological activities

B. S. Park, A. Z. Abdel-Azeem, M. M. Al-Sanea, K. H. Yoo, Jinsung Tae, S. H. Lee

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

In 1977 an unknown natural product was isolated from Streptomyces staurosporeus by Omura et al. during a search for new alkaloids present in actinomycetes and was given the name AM-2282. Later, the structure of AM-2282 was elucidated by single crystal X-ray analysis and renamed as staurosporine. It has been published that staurosporine and its analogues display strong inhibitory effect against a variety of kinases and a number of biological properties such as antifungal, antibacterial, and immunosuppressive activities. Despite strong inhibitory activity of staurosporine, a very high level of cross-reactivity makes it impossible to use staurosporine as a therapeutic agent. In the course of searching for other staurosporine-related compounds, a number of staurosporine analogues have been isolated from different microorganisms. In addition, a number of staurosporine analogues have been synthesized to improve the poor selectivity and target specificity of staurosporine which limited its clinical effectiveness. The review addresses staurosporine analogues from both microbial and synthetic sources and their biological activities.

Original languageEnglish
Pages (from-to)3872-3902
Number of pages31
JournalCurrent Medicinal Chemistry
Volume20
Issue number31
DOIs
Publication statusPublished - 2013 Oct 1

Fingerprint

Staurosporine
Bioactivity
Actinobacteria
X ray analysis
Streptomyces
Immunosuppressive Agents
Biological Products
Alkaloids
Microorganisms
Names
Phosphotransferases
X-Rays
Single crystals

All Science Journal Classification (ASJC) codes

  • Biochemistry
  • Molecular Medicine
  • Pharmacology
  • Drug Discovery
  • Organic Chemistry

Cite this

Park, B. S. ; Abdel-Azeem, A. Z. ; Al-Sanea, M. M. ; Yoo, K. H. ; Tae, Jinsung ; Lee, S. H. / Staurosporine analogues from microbial and synthetic sources and their biological activities. In: Current Medicinal Chemistry. 2013 ; Vol. 20, No. 31. pp. 3872-3902.
@article{2210f1650b66494db776597fbf49756a,
title = "Staurosporine analogues from microbial and synthetic sources and their biological activities",
abstract = "In 1977 an unknown natural product was isolated from Streptomyces staurosporeus by Omura et al. during a search for new alkaloids present in actinomycetes and was given the name AM-2282. Later, the structure of AM-2282 was elucidated by single crystal X-ray analysis and renamed as staurosporine. It has been published that staurosporine and its analogues display strong inhibitory effect against a variety of kinases and a number of biological properties such as antifungal, antibacterial, and immunosuppressive activities. Despite strong inhibitory activity of staurosporine, a very high level of cross-reactivity makes it impossible to use staurosporine as a therapeutic agent. In the course of searching for other staurosporine-related compounds, a number of staurosporine analogues have been isolated from different microorganisms. In addition, a number of staurosporine analogues have been synthesized to improve the poor selectivity and target specificity of staurosporine which limited its clinical effectiveness. The review addresses staurosporine analogues from both microbial and synthetic sources and their biological activities.",
author = "Park, {B. S.} and Abdel-Azeem, {A. Z.} and Al-Sanea, {M. M.} and Yoo, {K. H.} and Jinsung Tae and Lee, {S. H.}",
year = "2013",
month = "10",
day = "1",
doi = "10.2174/09298673113209990176",
language = "English",
volume = "20",
pages = "3872--3902",
journal = "Current Medicinal Chemistry",
issn = "0929-8673",
publisher = "Bentham Science Publishers B.V.",
number = "31",

}

Staurosporine analogues from microbial and synthetic sources and their biological activities. / Park, B. S.; Abdel-Azeem, A. Z.; Al-Sanea, M. M.; Yoo, K. H.; Tae, Jinsung; Lee, S. H.

In: Current Medicinal Chemistry, Vol. 20, No. 31, 01.10.2013, p. 3872-3902.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Staurosporine analogues from microbial and synthetic sources and their biological activities

AU - Park, B. S.

AU - Abdel-Azeem, A. Z.

AU - Al-Sanea, M. M.

AU - Yoo, K. H.

AU - Tae, Jinsung

AU - Lee, S. H.

PY - 2013/10/1

Y1 - 2013/10/1

N2 - In 1977 an unknown natural product was isolated from Streptomyces staurosporeus by Omura et al. during a search for new alkaloids present in actinomycetes and was given the name AM-2282. Later, the structure of AM-2282 was elucidated by single crystal X-ray analysis and renamed as staurosporine. It has been published that staurosporine and its analogues display strong inhibitory effect against a variety of kinases and a number of biological properties such as antifungal, antibacterial, and immunosuppressive activities. Despite strong inhibitory activity of staurosporine, a very high level of cross-reactivity makes it impossible to use staurosporine as a therapeutic agent. In the course of searching for other staurosporine-related compounds, a number of staurosporine analogues have been isolated from different microorganisms. In addition, a number of staurosporine analogues have been synthesized to improve the poor selectivity and target specificity of staurosporine which limited its clinical effectiveness. The review addresses staurosporine analogues from both microbial and synthetic sources and their biological activities.

AB - In 1977 an unknown natural product was isolated from Streptomyces staurosporeus by Omura et al. during a search for new alkaloids present in actinomycetes and was given the name AM-2282. Later, the structure of AM-2282 was elucidated by single crystal X-ray analysis and renamed as staurosporine. It has been published that staurosporine and its analogues display strong inhibitory effect against a variety of kinases and a number of biological properties such as antifungal, antibacterial, and immunosuppressive activities. Despite strong inhibitory activity of staurosporine, a very high level of cross-reactivity makes it impossible to use staurosporine as a therapeutic agent. In the course of searching for other staurosporine-related compounds, a number of staurosporine analogues have been isolated from different microorganisms. In addition, a number of staurosporine analogues have been synthesized to improve the poor selectivity and target specificity of staurosporine which limited its clinical effectiveness. The review addresses staurosporine analogues from both microbial and synthetic sources and their biological activities.

UR - http://www.scopus.com/inward/record.url?scp=84887922218&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84887922218&partnerID=8YFLogxK

U2 - 10.2174/09298673113209990176

DO - 10.2174/09298673113209990176

M3 - Article

C2 - 23848535

AN - SCOPUS:84887922218

VL - 20

SP - 3872

EP - 3902

JO - Current Medicinal Chemistry

JF - Current Medicinal Chemistry

SN - 0929-8673

IS - 31

ER -